Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration

Purpose: To evaluate the functional and anatomic outcomes of faricimab treatment in patients with neovascular age-related macular degeneration (nAMD) who are unresponsive to other anti-vascular endothelial growth factor (VEGF) therapies. Methods: A retrospective interventional study was conducted on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Anny M, Joshi, Sunir, Banoub, Raphael G, Saddemi, Jackson, Chalam, Kakarla V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328548/
https://www.ncbi.nlm.nih.gov/pubmed/37425528
http://dx.doi.org/10.7759/cureus.40100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328548/
https://www.ncbi.nlm.nih.gov/pubmed/37425528
http://dx.doi.org/10.7759/cureus.40100

Ejemplares similares